FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2070376293> ?p ?o ?g. }

• W2070376293 endingPage "116" @default.
• W2070376293 startingPage "116" @default.
• W2070376293 abstract "domain of the Her-2/neu tyrosine kinase to serum. We evaluated the correlation between the Her-2/neu status as determined by immunohistochemical analysis (IHC) and the serum Her-2/neu concentration in a population of Korean women with breast cancer. Methods: Serum Her-2/neu levels were examined from 254 female patients with primary breast cancer and 38 patients with metastatic breast cancer. Serum Her-2/neu levels were measured by the use of a chemiluminescence immunoassay (ADVIA centaur system) during the preoperative period. The level of Her-2/neu in all of the breast cancer tissue samples was determined by IHC, and samples with an IHC grade +2 were subject to fluorescence in situ (FISH). When tissue samples exhibited IHC grade +3 or showed amplification of Her-2/neu as determined by FISH analysis, Her-2/neu was considered overexpressed. The cut-off value for serum Her2/neu level was 10.2 ng/mL. Results: The mean serum Her-2/neu level was 10.1 ng/mL in primary breast cancer samples. The serum Her-2/neu concentration significantly correlated with expression of Her2/neu as determined by tissue IHC analysis (grade 1/3, 9.33 ±1.7 ng/mL; grade 2/3, 8.89±1.6 ng/mL; grade 3/3, 12.37 ±4.0 ng/mL, p<0.001). Increased serum HER-2/neu levels were associated with the lymph node status (p=0.003) and hormone unresponsiveness (p<0.001), tumor size (p<0.01) and age group (p<0.001). In metastatic breast cancer samples, the mean serum Her-2/neu level was 13.6 ng/mL. Elevated serum Her-2/neu levels were seen in 71.7% of metastatic breast cancer samples. The serum Her-2/neu level correlated with expression of Her-2/neu in metastatic tissue as determined by IHC analysis (p<0.001) rather than with the Her-2/neu status of the primary breast cancer (p=0.16) Conclusion: Serum Her-2/neu appears to be correlate with tissue Her-2/neu expression in primary and metastatic breast cancer where Her-2/neu is overexpressed. Further studies to determine levels of serum Her-2/neu are required to determine cuttoff values and the clinical application of the finding for breast cancer patients in Korea." @default.
• W2070376293 created "2016-06-24" @default.
• W2070376293 creator A5004494566 @default.
• W2070376293 creator A5016867614 @default.
• W2070376293 creator A5026459010 @default.
• W2070376293 creator A5038037948 @default.
• W2070376293 creator A5039331967 @default.
• W2070376293 creator A5039816597 @default.
• W2070376293 creator A5040045704 @default.
• W2070376293 creator A5070517482 @default.
• W2070376293 creator A5085858773 @default.
• W2070376293 date "2008-01-01" @default.
• W2070376293 modified "2023-10-05" @default.
• W2070376293 title "Correlation between the Her-2/neu Status as Determined by Immunohistochemical Analysis and the Serum Her-2/neu Concentration as Determined by the Use of ADVIA Cencaur® Automated Immunoassay in Breast Cancer Patients" @default.
• W2070376293 cites W176192392 @default.
• W2070376293 cites W1852564520 @default.
• W2070376293 cites W1901376003 @default.
• W2070376293 cites W1907754752 @default.
• W2070376293 cites W1966336226 @default.
• W2070376293 cites W1993135703 @default.
• W2070376293 cites W2004755792 @default.
• W2070376293 cites W2012492829 @default.
• W2070376293 cites W2039359329 @default.
• W2070376293 cites W2050411049 @default.
• W2070376293 cites W2069237867 @default.
• W2070376293 cites W2077778212 @default.
• W2070376293 cites W2084923342 @default.
• W2070376293 cites W2107005531 @default.
• W2070376293 cites W2111405387 @default.
• W2070376293 cites W2114069561 @default.
• W2070376293 cites W2121954422 @default.
• W2070376293 cites W2128448303 @default.
• W2070376293 cites W2130074283 @default.
• W2070376293 cites W2137399990 @default.
• W2070376293 cites W2148689234 @default.
• W2070376293 cites W2155912691 @default.
• W2070376293 cites W2156500288 @default.
• W2070376293 cites W2161428561 @default.
• W2070376293 cites W2392356861 @default.
• W2070376293 cites W317170036 @default.
• W2070376293 doi "https://doi.org/10.4048/jbc.2008.11.3.116" @default.
• W2070376293 hasPublicationYear "2008" @default.
• W2070376293 type Work @default.
• W2070376293 sameAs 2070376293 @default.
• W2070376293 citedByCount "2" @default.
• W2070376293 countsByYear W20703762932012 @default.
• W2070376293 crossrefType "journal-article" @default.
• W2070376293 hasAuthorship W2070376293A5004494566 @default.
• W2070376293 hasAuthorship W2070376293A5016867614 @default.
• W2070376293 hasAuthorship W2070376293A5026459010 @default.
• W2070376293 hasAuthorship W2070376293A5038037948 @default.
• W2070376293 hasAuthorship W2070376293A5039331967 @default.
• W2070376293 hasAuthorship W2070376293A5039816597 @default.
• W2070376293 hasAuthorship W2070376293A5040045704 @default.
• W2070376293 hasAuthorship W2070376293A5070517482 @default.
• W2070376293 hasAuthorship W2070376293A5085858773 @default.
• W2070376293 hasBestOaLocation W20703762931 @default.
• W2070376293 hasConcept C117220453 @default.
• W2070376293 hasConcept C121608353 @default.
• W2070376293 hasConcept C126322002 @default.
• W2070376293 hasConcept C142724271 @default.
• W2070376293 hasConcept C143998085 @default.
• W2070376293 hasConcept C159654299 @default.
• W2070376293 hasConcept C203014093 @default.
• W2070376293 hasConcept C204232928 @default.
• W2070376293 hasConcept C2524010 @default.
• W2070376293 hasConcept C2780420688 @default.
• W2070376293 hasConcept C29456083 @default.
• W2070376293 hasConcept C33923547 @default.
• W2070376293 hasConcept C530470458 @default.
• W2070376293 hasConcept C71924100 @default.
• W2070376293 hasConceptScore W2070376293C117220453 @default.
• W2070376293 hasConceptScore W2070376293C121608353 @default.
• W2070376293 hasConceptScore W2070376293C126322002 @default.
• W2070376293 hasConceptScore W2070376293C142724271 @default.
• W2070376293 hasConceptScore W2070376293C143998085 @default.
• W2070376293 hasConceptScore W2070376293C159654299 @default.
• W2070376293 hasConceptScore W2070376293C203014093 @default.
• W2070376293 hasConceptScore W2070376293C204232928 @default.
• W2070376293 hasConceptScore W2070376293C2524010 @default.
• W2070376293 hasConceptScore W2070376293C2780420688 @default.
• W2070376293 hasConceptScore W2070376293C29456083 @default.
• W2070376293 hasConceptScore W2070376293C33923547 @default.
• W2070376293 hasConceptScore W2070376293C530470458 @default.
• W2070376293 hasConceptScore W2070376293C71924100 @default.
• W2070376293 hasIssue "3" @default.
• W2070376293 hasLocation W20703762931 @default.
• W2070376293 hasOpenAccess W2070376293 @default.
• W2070376293 hasPrimaryLocation W20703762931 @default.
• W2070376293 hasRelatedWork W2055479802 @default.
• W2070376293 hasRelatedWork W2209229671 @default.
• W2070376293 hasRelatedWork W2355548861 @default.
• W2070376293 hasRelatedWork W2364961773 @default.
• W2070376293 hasRelatedWork W2381170207 @default.
• W2070376293 hasRelatedWork W2560061672 @default.
• W2070376293 hasRelatedWork W3026004524 @default.
• W2070376293 hasRelatedWork W3031174193 @default.
• W2070376293 hasRelatedWork W3109514250 @default.

• next